Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polonsky

Showing results (811-820 of 850) with videos related to

Pageof 85
Sort By:
Nature Communications|December 10, 2025
Potent neutralization by antibodies targeting the MPXV A28 proteinRon Yefet, Leandro Battini, Mathieu Hubert, et al.
Diabetes Care|September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal InsulinGrazia Aleppo, Roy W Beck, Ryan Bailey, et al.
JAMA|June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical TrialThomas Martens, Roy W Beck, Ryan Bailey, et al.
The New England Journal of Medicine|April 1, 2014
Survival with cardiac-resynchronization therapy in mild heart failureIlan Goldenberg, Valentina Kutyifa, Helmut U Klein, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
JAMA Cardiology|October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialAmber Sleem, Mark B Effron, Amanda Stebbins, et al.
The Pharmacogenomics Journal|February 5, 2019
Patient-provider communications about pharmacogenomic results increase patient recall of medication changesBrittany A Borden, Sang Mee Lee, Keith Danahey, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Consensus report of the coalition for clinical research-self-monitoring of blood glucoseDavid C Klonoff, Richard Bergenstal, Lawrence Blonde, et al.
American Heart Journal|June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEKamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
Pageof 85

Showing results (811-820 of 850) with videos related to

Sort By:
Pageof 85
Nature Communications|December 10, 2025
Potent neutralization by antibodies targeting the MPXV A28 proteinRon Yefet, Leandro Battini, Mathieu Hubert, et al.
Diabetes Care|September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal InsulinGrazia Aleppo, Roy W Beck, Ryan Bailey, et al.
JAMA|June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical TrialThomas Martens, Roy W Beck, Ryan Bailey, et al.
The New England Journal of Medicine|April 1, 2014
Survival with cardiac-resynchronization therapy in mild heart failureIlan Goldenberg, Valentina Kutyifa, Helmut U Klein, et al.
Diabetes Research and Clinical Practice|July 19, 2022
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 SystemWilliam H Polonsky, Korey K Hood, Carol J Levy, et al.
Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
JAMA Cardiology|October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialAmber Sleem, Mark B Effron, Amanda Stebbins, et al.
The Pharmacogenomics Journal|February 5, 2019
Patient-provider communications about pharmacogenomic results increase patient recall of medication changesBrittany A Borden, Sang Mee Lee, Keith Danahey, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Consensus report of the coalition for clinical research-self-monitoring of blood glucoseDavid C Klonoff, Richard Bergenstal, Lawrence Blonde, et al.
American Heart Journal|June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEKamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
Pageof 85